The effects of risperidone on the cognitive performance of individuals with schizotypal personality disorder
- PMID: 19593186
- PMCID: PMC4176874
- DOI: 10.1097/JCP.0b013e3181accfd9
The effects of risperidone on the cognitive performance of individuals with schizotypal personality disorder
References
-
- Reichenberg A, Weiser M, Caspi A, et al. Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders. J Clin Exp Neuropsychol. 2006;28(2):193–207. - PubMed
-
- Heinrichs RW. The primacy of cognition in schizophrenia. Am Psychol. 2005;60(3):229–242. - PubMed
-
- Milev P, Ho BC, Arndt S, et al. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry. 2005;162(3):495–506. - PubMed
-
- Bilder RM, Goldman RS, Volavka J, et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry. 2002;159(6):1018–1028. - PubMed
-
- Kraepelin E. Dementia praecox. In: Cutting J, Shepherd M, editors. The Clinical Roots of the Schizophrenia Concept: Translations of Seminal European Contributions on Schizophrenia. New York (NY): Cambridge University Press; 1987. pp. 13–24.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources